423, Hindry Avenue
CA 90301 INGLEWWOD - USA Site web

Key figures

Creation date: 2007
Number of employees: 12
Investment date: 18/02/2012
Fund name: Mérieux Participations 1

Key contacts

Company presentation

ImaginAb is redefining therapeutic management by harnessing the power of antibody technology for in vivo imaging. The proprietary platform of antibody fragments  provides molecular information to guide treatment decisions in oncology and immunology. ImaginAb also cooperates with biopharmaceutical partners to design imaging agents that will become companions diagnostic of therapeutic antibodies. The ImaginAb technology is positioned to help personalized medicine deliver its promises, namely, improving patient outcomes and reducing health care costs.